MRSA screening in ICU cost effective.
MRSA screening in ICU cost effective. MRSA screening of patients in the intensive-care unit (ICU) produces cost savings for the whole hospital, according to a study published in the February 2011 issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC). Researchers at the Minneapolis Veterans Affairs Medical Center found that, even under the most conservative assumptions, screening would be cost-neutral if early detection of MRSA led to a reduced rate of infection and transmission within the hospital. Under optimal assumptions, screening could result in savings of almost $500 per hospital admission. A 2006 survey conducted by APIC showed that 46 out of every 1,000 inpatients were infected or colonized with MRSA.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Infectious diseases|
|Publication:||Medical Laboratory Observer|
|Article Type:||Brief article|
|Date:||Mar 1, 2011|
|Previous Article:||Study suggests screening for MRSA in the nose.|
|Next Article:||Spread the word, not the flu.|